Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations.
Gougelet A, Sartor C, Bachelot L, Godard C, Marchiol C, Renault G, Tores F, Nitschke P, Cavard C, Terris B, Perret C, Colnot S.
Gougelet A, et al. Among authors: cavard c.
Gut. 2016 Jun;65(6):1024-34. doi: 10.1136/gutjnl-2014-308969. Epub 2015 Mar 19.
Gut. 2016.
PMID: 25792709
Free article.